Serious Hazards of Transfusion. Annual report 2000–2001. Serious Hazards of Transfusion Scheme, Manchester, UK, 2002. (www.shotuk.org).
2.
British Committee for Standards in Haematology 1999. The administration of blood and blood components and the management of transfused patients. Transfusion Medicine1999; 9: 227–238.
3.
TurnerCCasbardAC & MurphyMF. Barcode technology: Its role in increasing the safety of blood transfusion. Transfusion2003 (in press).
RobertsI. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials. British Medical Journal1998; 317: 235–240.
6.
HebertPCWellsGBlajchmanMAMarshallJMartinCPagliarelloGTweedaleMSchweitzerI, Yetisir E, and the Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. New England Journal of Medicine1999; 340: 409–417.
7.
Department of Health (1998). Health Services Circular (HSC 1998/224). Better Blood Transfusion (www.doh.gov.uk/bbt2).
8.
Department of Health (2002). Health Services Circular (HSC 2002/009). Better Blood Transfusion — Appropriate Use of Blood (www.doh.gov.uk/bbt2).
9.
MurphyMFEdburyC & WickendenC. Survey of the implementation of the recommendations in the Health Services Circular 1998/224 ‘Better Blood Transfusion’. Transfusion Medicine2003; 13: 121–125.
10.
MurphyMFWilkinsonJLoweD & PearsonM. (2001). National audit of the transfusion process. Transfusion Medicine200; 11: 363–370.